BridgeBio Pharma Reports Third Quarter 2021 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
BridgeBio Pharma Inc. (BBIO) Misses Q3 EPS by 16c
November 4, 2021 7:37 AM EDTBridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q3 EPS of ($1.06), $0.16 worse than the analyst estimate of ($0.90).
For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.
... More